Trends of diabetic nephropathy prevalence in Isfahan, Iran, during 1992-2010
暂无分享,去创建一个
[1] A. Ernest,et al. Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania , 2016, BMC Nephrology.
[2] K. Tuttle,et al. Novel therapies for diabetic kidney disease. , 2013, Advances in chronic kidney disease.
[3] G. Kishore,et al. Risk factors and management of diabetic nephropathy. , 2013, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[4] A. Al-Agha,et al. Occurrence of microalbuminuria among children and adolescents with insulin-dependent diabetes mellitus. , 2013, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[5] C. Thompson. Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors. , 2013, World journal of diabetes.
[6] Zhaohu Hao,et al. [Analyses on the relative factors regarding diabetic nephropathy]. , 2013, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[7] Nan Chen,et al. Prevalence of chronic kidney disease in China: a cross-sectional survey , 2012, The Lancet.
[8] F. Amani,et al. Applying Segmented Regression Model to Analysis the Trend of Tuberculosis Incidence Rate in Iran Between 1964 -2008 , 2011 .
[9] Patrick J Heagerty,et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.
[10] Chris Jones. Biomarkers of Kidney Disease , 2011 .
[11] Zumin Shi. Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.
[12] K. Dou,et al. Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.
[13] G. Rossi,et al. Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003). , 2008, Diabetes Care.
[14] Chih-Cheng Hsu,et al. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] K. Land,et al. A Mixed Models Approach to the Age-Period-Cohort Analysis of Repeated Cross-Section Surveys, with an Application to Data on Trends in Verbal Test Scores , 2006 .
[16] Daniel W. Jones,et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.
[17] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[18] S. Haghighi,et al. Costs of type 2 Diabetes in Isfahan – Iran in 1998 , 2002 .
[19] E. Feuer,et al. Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.
[20] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[21] B. Freedman,et al. Family history of end-stage renal disease among incident dialysis patients. , 1997, Journal of the American Society of Nephrology : JASN.
[22] J. Himmelfarb,et al. New therapies for diabetic kidney disease. , 2013, The New England journal of medicine.
[23] H. Alireza,et al. ECONOMICS COST OF DIABETES IN TYPE II DIABETIC PATIENTS , 2012 .
[24] Sharifirad Gholamreza,et al. THE RELATIONSHIP BETWEEN SOCIOECONOMIC FACTORS AND THEIR EFFECTS ON PATIENTS WITH TYPE 2 DIABETES , 2011 .
[25] C. Edelstein. Biomarkers in kidney disease , 2011 .